We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Mass Spectrometry Detection for the Masses

By LabMedica International staff writers
Posted on 17 Jul 2017
Print article
Image: Research being conducted uses an atmospheric-pressure glow discharge plasma to probe samples for elemental and molecular species, and could lead to user-friendly MS analyses with broad capabilities (Photo courtesy of the Rensselaer Polytechnic Institute).
Image: Research being conducted uses an atmospheric-pressure glow discharge plasma to probe samples for elemental and molecular species, and could lead to user-friendly MS analyses with broad capabilities (Photo courtesy of the Rensselaer Polytechnic Institute).
Researchers are developing a plasma-based technology to enable generalized use of mass spectrometry (MS) with new instruments that can analyze a much broader range of molecular species than current technology allows.

Current MS instruments are bulky, expensive, and typically specialize in one class of chemicals, discouraging widespread use outside of a specialized lab setting. Better technology is needed to make more flexible instruments. Research being conducted at Rensselaer Polytechnic Institute (Troy, NY, USA) uses an atmospheric-pressure glow discharge plasma – a partially ionized gas that can be made stable at room temperature and pressure – to probe samples for elemental and molecular species, and could lead to user-friendly MS analyses with broad capabilities.

“Ideally we want one system that can detect everything, and we want to be able to take that system into the field to test materials on site,” said Prof. Jacob Shelley of Rensselaer Polytechnic, “We’re trying to make a more flexible instrument that will allow us to detect many things simultaneously.”

The hitch is that current instruments can only analyze molecules that are in gas state and ionized, which means that most samples must first be processed. Current MS relies on a variety of time-consuming processing methods that separate and ionize molecules prior to analysis. And depending on the method, samples (e.g. tissues, pharmaceuticals, or foods) may be destroyed during processing.

The biggest challenge to developing a generalized processing method is the chemistry needed to ionize the molecule. Most methods rely on specific chemistries that favor ionization of one class of molecules over another. Prof. Shelley team is developing a method that takes advantage of the unusual properties and chemistries of plasmas, which are rich in free-moving ions and electrons, and therefore highly interactive. Although the most commonly known plasmas are extremely hot (at nearly 10,000 degrees Kelvin, some plasmas rival the sun’s temperature), the team is working with more recently developed glow discharge plasmas that are stable at room temperature and atmospheric pressure.

In his lab, Prof. Shelley demonstrates an experimental instrument so benign it can test samples ionized from a fingertip, and so versatile it can detect molecular species from small amounts of metals to large labile biomolecules like peptides and proteins. In developing the technology, the team has used the instrument to detect counterfeit honey, to quantify harmful toxins in freshwater algal blooms, and to screen the raw materials used in nutritional supplements.

“The plasma is useful as an ionization source because it makes a diverse range of chemistries available,” said Prof. Shelley, “It may make it possible to ionize a broad class of molecules, which could lead to more generalized instruments.”

This research is enabled by the New Polytechnic vision, a transformative emerging paradigm for higher education, which recognizes that even the most talented person working alone cannot adequately address global challenges and opportunities. It helps Rensselaer serve as a crossroads for collaborations to address some of the world’s most pressing technological challenges.

Related Links:
Rensselaer Polytechnic Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.